A cost minimisation analysis of navelbine-cisplatin versus gemcitabine-cisplatin in advanced nonsmall cell lung cancer in Poland

被引：0
|
作者：
Skowron, A. [1 ]
Polak, S. [1 ]
Brandys, J. [1 ]
机构：
[1] Jagiellonian Univ, Krakow, Malopolska, Poland
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)63461-4
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A285 / A285
页数：1
相关论文
共 50 条
  • [21] First-Line Gemcitabine Plus Cisplatin in Nonsmall Cell Lung Cancer Patients
    Li, Ying
    Wang, Lin Run
    Chen, Jian
    Lou, Yan
    Zhang, Guo Bing
    DISEASE MARKERS, 2014, 2014
  • [22] Economic Evaluation of Gemcitabine Alone and in Combination with Cisplatin in the Treatment of Nonsmall Cell Lung Cancer
    M. Lees
    M. Aristides
    N. Maniadakis
    J. McKendrick
    N. Botwood
    D. Stephenson
    PharmacoEconomics, 2002, 20 : 325 - 337
  • [23] A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma
    Joaquín Casal Rubio
    S. Vázquez
    F. Vázquez
    M. Amenedo
    J. L. Fírvida
    J. R. Mel
    G. Huidobro
    E. Álvarez
    M. Lázaro
    G. Alonso
    I. Fernández
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 379 - 384
  • [24] A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma
    Casal Rubio, Joaquin
    Vazquez, S.
    Vazquez, F.
    Amenedo, M.
    Firvida, J. L.
    Mel, J. R.
    Huidobro, G.
    Alvarez, E.
    Lazaro, M.
    Alonso, G.
    Fernandez, I.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 379 - 384
  • [25] Economic evaluation of gemcitabine alone and in combination with cisplatin in the treatment of nonsmall cell lung cancer
    Lees, M
    Aristides, M
    Maniadakis, N
    McKendrick, J
    Botwood, N
    Stephenson, D
    PHARMACOECONOMICS, 2002, 20 (05) : 325 - 337
  • [26] VINORELBINE VERSUS VINORELBINE PLUS CISPLATIN IN ADVANCED NONSMALL CELL LUNG-CANCER - A RANDOMIZED TRIAL
    DEPIERRE, A
    CHASTANG, C
    QUOIX, E
    LEBEAU, B
    BLANCHON, F
    PAILLOT, N
    LEMARIE, E
    MILLERON, B
    MORO, D
    CLAVIER, J
    HERMAN, D
    TUCHAIS, E
    JACOULET, P
    BRECHOT, JM
    CORDIER, JF
    SOLALCELIGNY, P
    BADRI, N
    BESENVAL, M
    ANNALS OF ONCOLOGY, 1994, 5 (01) : 37 - 42
  • [27] Safety and Pharmacokinetics ofMotesanib in Combination with Panitumumab and Gemcitabine-Cisplatin in Patients with Advanced Cancer
    Burris, Howard
    Stephenson, Joe
    Otterson, Gregory A.
    Stein, Mark
    McGreivy, Jesse
    Sun, Yu-Nien
    Ingram, Megan
    Ye, Yining
    Schwartzberg, Lee S.
    JOURNAL OF ONCOLOGY, 2011, 2011
  • [28] The effectiveness of vinorelbine plus cisplatin versus gemcitabine plus cisplatin in local advanced non-small cell lung cancer
    Koemuercueoglu, B.
    Aydogan, H.
    Tekguel, S.
    Cecen, E.
    Yalniz, E.
    Oezden, E. Pala
    LUNG CANCER, 2006, 52 : S36 - S36
  • [29] Gemcitabine and cisplatin in advanced non small cell lung cancer (NSCLC)
    Garcia-Gomez, R
    Lopez-Criado, P
    Guevara, S
    Lahoz, C
    Chaib, C
    Gonzalez, C
    Santiago, J
    De Alvaro, J
    Carrion, R
    Perez-Manga, G
    ANNALS OF ONCOLOGY, 1998, 9 : 93 - 94
  • [30] Comparison of the Efficacy between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer
    Lee, Jieun
    Hong, Tae Ho
    Lee, In Seok
    You, Young Kyoung
    Lee, Myung Ah
    CANCER RESEARCH AND TREATMENT, 2015, 47 (02): : 259 - 265
12345